Neurofix Pharma
PrivateLast Round
Crowdfunding
May 19, 2023
Est. Valuation
$23.79M
Total Funding Raised
$5.84M
Company Overview
Neurofix Pharma is a biotechnology company that researches and develops lipid-based therapies for the treatment of central nervous system disorders, including neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurofix Pharma Comparables
Compare Neurofix Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNetX Bio | 75% | |
| NervGen Pharma Corp. | 72% | |
| Neuroplast | 70% |
Neurofix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | May 19, 2023 | ||||
| VC Round | Nov 16, 2022 | ||||
| Crowdfunding | Jan 18, 2022 | ||||
| Crowdfunding | Sep 8, 2021 | ||||
| VC Round | Aug 14, 2020 |
Key People
Founding team and executive leadership
Neurofix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nowture | VC Round |
| Fellow Funders | Crowdfunding |
| Capital Cell | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2022
Raised $4M led by Capital Cell
- Sep 8, 2021
$1.06M raised led by Fellow Funders
Neurofix Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurofix Pharma's valuation, stock price, and market status.
Is Neurofix Pharma a public or private company?
Neurofix Pharma is a private company.
What is the current stock price of Neurofix Pharma?
Neurofix Pharma is a private company with no public stock price. Caplight tracks Neurofix Pharma's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Neurofix Pharma worth (valuation)?
Neurofix Pharma's valuation is estimated at $23.8M based on funding round data.
Can I buy Neurofix Pharma stock?
Neurofix Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurofix Pharma's last funding round?
Neurofix Pharma's most recent funding round was Crowdfunding on May 19, 2023.
Who are the main investors in Neurofix Pharma?
Key investors in Neurofix Pharma include Nowture, Fellow Funders, Capital Cell.
Will Neurofix Pharma IPO soon?
No public IPO plans have been announced for Neurofix Pharma.
How can I track Neurofix Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurofix Pharma's secondary market activity and sign up for updates.